Melanie De Almeida
This Swedish Biotech Uses Bacteria to Treat Diseases in Infants
New Biochips Quickly Identify the Best Antibiotic for each Bacterial Infection
A Cheaper Heat-Stable Vaccine Could Prevent Child Deaths in Africa
Galapagos Enters Clinical Trials with New Cystic Fibrosis Drug
Speed up R&D? Eppendorf is Offering a new Solution!
Swedish Oncology Biotech Teams up with World Leading Cancer Center
France’s 2nd Biggest Pharma Enters New Partnership for Immunotherapies
A Potential First Treatment for a Rare Genetic Disease clears Phase I
New Treatment for Amyotrophic Lateral Sclerosis Passes Phase III Trials
Will BMS Take Over a Danish Biotech in a Massive €500M Deal?
UPDATE: Swiss Medtech cancels IPO and goes for Record €411M Exit
French Biotech fails Second Phase II Trial for Cardiovascular Disease
Labiotech UG, All Rights Reserved -
Send this to friend